Newsletter
| Promoter: | Penny Stock Pick Alert | Paying Party: | Equities Awareness Group |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| MFTH | $17500 | 16049 |
| Max Profit: 2.80 % | Gain at close: -22.12 % | |
| *We think that this promoter is a part of a group of promoters. | ||
Good morning, Traders,
MFTH (Medisafe 1 Technologies) - released revenue related news that I expect could generate positive sentiment about the Company's growth prospects.
MFTH's breakthrough medical technology has the potential to grab a piece of the over five billion dollar syringe market...
...and this morning Medisafe announced that it expects Sales to jump to over the ten million mark.
Medisafe 1 Technologies Expects Revenues to Exceed Ten Million in 2012
January 24, 2011 /PRNewswire via COMTEX/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company expects revenues in 2012 to exceed ten million dollars .
January 24, 2011 /PRNewswire via COMTEX/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company expects revenues in 2012 to exceed ten million dollars .
Revenues will be derived from the licensing of Medisafe 1 Technology's patented locking devices on syringes and the licensing of the related Bar-Code Pre-Matching safety device software application . The patent is also applicable to intravenous infusion and transfusion bags.
Discussions for licensing the technology devices are already underway in Israel, where the technology is expected to eventually be implemented across the State's nationwide medical system.
Medisafe 1 Technologies is currently attempting to enter into additional markets for its lifesaving technologies.
"Many reputable organizations and companies have expressed the value they recognize in our technologies," said, Jacob Elhadad, CEO of Medisafe 1 Technologies. "Through the further development of existing marketing channels, and the mass production of our licensed products, we expect reporting revenues in 2012 to exceed ten million dollars."
About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
To read the press release in full, please visit: http://finance.yahoo.com/news/Medisafe-1-Technologies-prnews-1473272581.html?x=0&.v=1
--------------------------------
MFTH has developed a solution to a several hundred billion dollar world healthcare issue.
Keep watching for more developments.
Best Regards,
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. ****************************************************************************************************************** The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: The PennyStockPickAlert employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://www.pennystockpickalert.com/disclaimer Release of Liability: Through use of this website viewing or using you agree to hold PennyStockPickAlert, its operators owners and employees harmless and to compltely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. PennyStockPickAlert's affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. PennyStockPickAlert has been compensated seventeen thousand five hundred thousand dollars for a one day investor awareness marketing campaign by Equities Awareness Group. All information on featured companies is provided by the companies profiled, or is available from public sources and PennyStockPickAlert makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to or sell any securities. Any claims or Statements should be deemed apocryphal. PennyStockPickAlert, nor any of its affiliates are not registered investment advisors or a broker dealers.PennyStockPickAlert encourages readers and investors to supplement the information in these reports with independent research and other pro advice. PennyStockPickAlert encourages readers and investors to supplement the information in these reports with independent research and other pro advice.